Savara Inc — Director's Dealing 2014

Jun 20, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Mast Therapeutics, Inc. (MSTX)
CIK: 0001160308
Period of Report: 2014-06-19

Reporting Person: Vetticaden Santosh (Chief Medical Officer & SVP)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-06-19	Stock Option (Right to Buy)	$0.65	A	529300	Acquired	2024-06-19	Common Stock (529300)	Direct

Footnotes

F1: This option vests and becomes exercisable in 48 substantially equal monthly installments on each monthly anniversary of June 19, 2014, subject to the reporting person's continued service with the issuer.